{"metadata": {"source": "erowid", "title": "Erowid Psilocybin & Psilocin Vault : Legal Status", "description": "Information on the legal status of Psilocybin & Psilocin.", "language": "No language found.", "url": "https://www.erowid.org/chemicals/psilocybin/psilocybin_law.shtml", "drug": "Psilocybin", "cid": 10624, "substance": "psilocybin", "category": "CHEMICALS", "erowid_column": "Law", "char_count": 7199, "word_count": 1021, "doc_id": "doc_219", "num_chunks": 9, "chunk_id": "219::chunk_5", "document_index": 219, "latency_s": 0.8161846000002697, "prompt_toks": 2173, "completion_toks": 72, "relevance_score": 0.0017683518}, "content": "Drug: Psilocybin | cid: 10624\nSource: erowid | Source description: Information on the legal status of Psilocybin & Psilocin.\nErowid name: psilocybin\nCategory: CHEMICALS\nField: Law\n\n                    Text: \n                    The SF-bay area city of Oakland de-prioritized / decriminalized the possession of \"entheogenic plants\" including psilocybin mushrooms, mescaline-containing cacti, iboga, and DMT-containing plants such as those used in ayahuasca on June 4 2019 at 23:12 (11:12pm) on a \"unanimous vote\" (although it appeared at least one councilperson abstained. This effort was lead by Decriminalize Nature Oakland. The Oakland resolution did not decriminalize opiate-containing plants. Congratulations to those who worked this successful campaign! The text of the resolution included: \"RESOLVED, That the Mayor and City Council hereby declare that it shall be the policy of the City of Oakland that no department, agency, board, commission, officer or employee of the city, including without limitation, Oakland Police Department personnel, shall use any city funds or resources to assist in the enforcement of laws imposing criminal penalties for the use and possession of Entheogenic Plants by adults; [... and\n\n\n                    Context: \n                    This excerpt details Oakland's 2019 resolution to de-prioritize law enforcement against entheogenic plants like psilocybin mushrooms and DMT-containing plants, illustrating changes in local drug policy. It provides specific legal and procedural information relevant to the broader discussion of psilocybin's legal status and law reform efforts within the comprehensive Erowid resource.\n                "}
{"metadata": {"source": "erowid", "title": "Erowid Psilocybin & Psilocin Vault : Legal Status", "description": "Information on the legal status of Psilocybin & Psilocin.", "language": "No language found.", "url": "https://www.erowid.org/chemicals/psilocybin/psilocybin_law.shtml", "drug": "Psilocybin", "cid": 10624, "substance": "psilocybin", "category": "CHEMICALS", "erowid_column": "Law", "char_count": 7199, "word_count": 1021, "doc_id": "doc_219", "num_chunks": 9, "chunk_id": "219::chunk_6", "document_index": 219, "latency_s": 1.2673293999978341, "prompt_toks": 2082, "completion_toks": 83, "relevance_score": 0.0012545944}, "content": "Drug: Psilocybin | cid: 10624\nSource: erowid | Source description: Information on the legal status of Psilocybin & Psilocin.\nErowid name: psilocybin\nCategory: CHEMICALS\nField: Law\n\n                    Text: \n                    Department personnel, shall use any city funds or resources to assist in the enforcement of laws imposing criminal penalties for the use and possession of Entheogenic Plants by adults; [... and ...] RESOLVED That the Mayor and City Council hereby declare that it shall be the policy of the City of Oakland that the investigation and arrest of adult persons for planting, cultivating, purchasing, transporting, distributing, engaging in practices with, and/or possessing Entheogenic Plants or plant compounds on the Federal Schedule 1 list shall be amongst the lowest law enforcement priority for the City of Oakland; [...]\" (last updated June 4 2019)\n\n\n                    Context: \n                    This excerpt details Oakland's local policy prioritizing decriminalization and low enforcement regarding entheogenic plants, including psilocybin mushrooms, within the broader context of the webpage's focus on drug legality and law reform at state and international levels. It highlights Oakland's specific resolution on deprioritizing investigations and arrests related to Schedule 1 entheogenic plants, emphasizing its significance in current legal and activism discussions.\n                "}
{"metadata": {"source": "psychonaut", "title": "Cannabidiol - PsychonautWiki", "description": "Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/CBD", "drug": "CBD", "cid": 644019, "char_count": 21724, "word_count": 3040, "doc_id": "doc_84", "num_chunks": 28, "chunk_id": "84::chunk_18", "document_index": 84, "latency_s": 0.6062388999998802, "prompt_toks": 6408, "completion_toks": 51, "relevance_score": 6.657016e-05}, "content": "Drug: CBD | cid: 644019\nSource: psychonaut | Source description: Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.\n\n                    Text: \n                    ↑ Angell, T. (2018), UN Launches First-Ever Full Review Of Marijuana’s Status Under International Law\n\n↑ Iffland, Kerstin; Grotenhermen, Franjo (2017). \"An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies\". Cannabis and Cannabinoid Research. 2 (1): 139–154. doi:10.1089/can.2016.0034. ISSN 2378-8763.\n\n↑ 7.0 7.1 Mechoulam, R., Hanuš, L. (December 2002). \"Cannabidiol: an overview of some chemical and pharmacological aspects. Part I: chemical aspects\". Chemistry and Physics of Lipids. 121 (1–2): 35–43. doi:10.1016/S0009-3084(02)00144-5. ISSN 0009-3084.\n\n↑ How the Associated Press collected information on CBD vapes, 2019\n\n↑ Sharma, P., Murthy, P., Bharath, M. M. S. (2012). \"Chemistry, metabolism, and toxicology of cannabis: clinical implications\". Iranian Journal of Psychiatry. 7 (4): 149–156. ISSN 1735-4587.\n\n\n                    Context: \n                    This excerpt lists key academic and industry references related to cannabidiol (CBD), including scholarly reviews on its safety and side effects, chemical properties, and research developments, providing authoritative sources within the broader comprehensive overview of CBD covered in the full webpage content.\n                "}
